SAFETY AND EFFICACY OF LENABASUM IN AN OPEN-LABEL EXTENSION OF A PHASE 2 STUDY IN DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS SUBJECTS (DCSSC) Spiera, R., Hummers, L., Chung, L., Frech, T., Domsic, R., Hsu, V., Furst, D., Gordon, J., Mayes, M., Simms, R., Lee, E., Constantine, S., Dgetluck, N., White, B. BMJ PUBLISHING GROUP. 2019: 245

View details for DOI 10.1136/annrheumdis-2019-eular.3390

View details for Web of Science ID 000472207100538